Key Highlights
- Danaher's $0.40 quarterly Dividend trades ex-date September 30, 2026, payable October 30, up from $0.32 paid in January.
- Second-quarter net Earnings were $870 million, or $1.23 per diluted share, up 60%, while adjusted EPS rose 8.0% to $1.94.
- Revenue rose 5.5% to $6.3 billion, and Operating Cash Flow was $1.5 billion with non-GAAP free cash flow of $1.3 billion.
- Julie Sawyer Montgomery becomes President and CEO on October 1, succeeding Rainer Blair.
Overview
Danaher Corporation's (NYSE:DHR) $0.40 quarterly dividend yields approximately 0.71% and equals $1.60 annualized, up 25% from the $0.32 paid on January 30, 2026. The dividend equals approximately 33% of second-quarter GAAP diluted earnings of $1.23 per share and approximately 21% of non-GAAP adjusted diluted earnings of $1.94. The company completed its Acquisition of Masimo Corporation earlier than anticipated.
Dividend Program and Shareholder Returns
The board approved a regular quarterly Cash Dividend of $0.40 per share on September 15, payable October 30 to holders of record on September 30. The rate equals $1.60 annualized.
Danaher paid $0.32 per share on January 30, 2026, then $0.40 on April 24 and $0.40 on July 31. The Board approves the dividend each quarter.
About the Company
Danaher is a global life sciences and diagnostics innovator, applying the Danaher Business System to help move innovations from discovery to delivery. Its results reflect continuing operations and depend on laboratory and research spending, biopharmaceutical demand, diagnostic testing volumes, consumables and acquisitions. It completed the acquisition of Masimo Corporation in 2026, ahead of its original timeline.
Financial Performance Behind the Payout
Danaher reported second-quarter net earnings of $870 million, or $1.23 per diluted share, up 60% year over year. Non-GAAP adjusted diluted EPS rose 8.0% to $1.94. Revenue increased 5.5% to $6.3 billion, non-GAAP core revenue rose 3.0%, and core revenue excluding respiratory testing rose 4.5%. Operating cash flow was $1.5 billion and non-GAAP free cash flow was $1.3 billion.
Pretax items related to the Masimo acquisition were $108 million for the quarter and $125 million for the six months. The company said the strong second-quarter earnings performance and the early completion of the Masimo acquisition enabled it to increase its full-year 2026 adjusted diluted EPS guidance. For the third quarter, it anticipates non-GAAP core revenue growth of 2.0% to 3.0%.
A Dividend Increase Ahead of a CEO Transition and Masimo Integration
The company announced on August 3 that its board appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a director, effective October 1, 2026. Rainer Blair will retire on that date and serve as a senior advisor until March 31, 2027. Ms. Sawyer Montgomery is Executive Vice President for the Diagnostics platform and joined Danaher in 2017 at Beckman Coulter Diagnostics.
The $0.40 dividend equals approximately 33% of GAAP diluted EPS and approximately 21% of non-GAAP adjusted diluted EPS for the quarter, both computed from the figures above. GAAP EPS of $1.23 and adjusted EPS of $1.94 differ by amounts including acquisition-related items.
Outlook
Danaher's quarterly dividend is $0.40 per share. Integration of Masimo, core revenue growth relative to the 2.0% to 3.0% third-quarter range, and free cash flow relative to the $1.3 billion reported this quarter are the relevant considerations.

_09_30_2026_02_08_20_566201.jpg)




Please wait processing your request...